Yunfeng Li

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

Shukui Qin, Jin Li, Liwei Wang et al. · Journal of Clinical Oncology · 2018 · 257 citations · Full text

Medicine, Oncology, Pharmacology +12

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial

Wei-Jian Mei, Xiaozhong Wang, Yunfeng Li et al. · Annals of Surgery · 2022 · 82 citations · Full text

Medicine, Oncology, Surgery +17

Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial

Huabin Hu, Jianwei Zhang, Yunfeng Li et al. · Journal of Clinical Oncology · 2024 · 63 citations

Medicine, Oncology, Surgery +17

Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability

Tao Wu, Xuan Zhang, Xinxing Liu et al. · BMC Medicine · 2023 · 46 citations · Full text

Medicine, Immunology, Oncology +17

Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer

Binyi Xiao, Xuan Zhang, Taiyuan Cao et al. · Journal of the National Comprehensive Cancer Network · 2023 · 40 citations · Full text

Medicine, Immunology, Oncology +17